In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko  write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.